1. Research Strategic Plan
David W. Niesel, PhD
Chief Research Officer
SVP and Dean GSBS

2. Research Strategic Plan Research Planning Task Force
Mariano Garcia-Blanco, MD, PhD Chair, BMB Kenneth Ottenbacher, PhD Professor, Rehab. Sciences Douglas Tyler, MD Chair, Surgery Michael Laposata, MD, PhD Chair, Pathology Kathryn Cunningham, PhD Director, CAR Allan Brasier, MD Director, ITS Nisha Garg, PhD Professor M&I and Assoc. Dir. IHII Andrew McNees, PhD, MBA Director, Research Ops. And Logistics Toni D’Agostino, MA Assoc. VP, Research Administration David W. Niesel, PhD Chief Research Officer

3. Strategic Management Timeline
Process and Deliverables
Resource Summary and Prioritization
Implementation Plan
Performance Monitoring & Reporting OnFocus
Strategic Plan Adoption
Engage Participants
Drivers of Research
UTMB Research 2020 Development
Draft Goals/Objectives
Future Picture Adoption
Goal Adoption
Objective Refinement
Tactical Plan Development
Adoption Process
Target Setting
Future Picture
Aug 15
Sept 16
June 15
Mar 16
Nov 16
Infrastructure Discipline
KPI Inventory
Infrastructure
Research Portfolio
Budgeting Process
Center/Institute Assessment
Performance Monitoring and Reporting for FY16 and Preliminary FY17/Beyond
Design and Recommend
Assessment

5. Objectives Selected Optimize Clinical Research Infrastructure
Expand imaging capabilities and capacity in support of all research areas
Expand interdisciplinary research activity in Infection and Immunology
Coordinate selective expansion of informatics development across and throughout research enterprise
Expand interdisciplinary research activity in Neurodysfuntion
Expand interdisciplinary research activity in Physical Medicine and Rehabilitation
Expand interdisciplinary research activity in Pulmonary and Cardiovascular
Increase Vaccine Development and Drug discovery activity

6. Top 5 Priority Objectives Resource Requirements
Capital FY17
Capital FY18
One Time FY17
One Time FY18
Ongoing FY17
Ongoing FY18
New Faculty
New Staff
Optimize Clinical Research Infrastructure
Increase Vaccine development and Drug discovery activity by xx% annually through 4FQ17 $ $ $ $
3.00
Coordinate selective expansion of informatics development across and throughout research enterprise $ $ $
$ 1,120 $ $
3.20
Expand interdisciplinary research activity in Infection and Immunology by 4FQ17 $ $ $
2.00
0.50
Expand interdisciplinary research activity in Neurodysfuntion by 4FQ17
$ 4,200
$ 2,700
$ 5,000
$ 1,800
$ 2,350
Grand Total
$ 4,925
$ 3,450
$ 6,010
$ 1,785
$ 3,123
$ 4,448
8.70

7. Why Neurodysfunction? Build on existing strengths Neuroinfection
Addiction
Pain
Traumatic Brain Injury
Rehabilitation science
Alzheimer’s / Cognitive dysfunction
Alignment with Clinical strategic plan to expand neurosciences
Ongoing recruitment of new faculty
Neuroscience
CAR addiction psychiatrist
Thursday, October 13, 2016
Many new projects explore human brain activity.
The National Institutes of Health announced its third round of grants to support the goals of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative,
bringing NIH’s total fiscal year 2016 investment to just over $150 million.

9. Convergence around Investments in Neuroscience
National
Neuroscience research is a high Priority for NIH
NIH Brain Initiative (UTS is 1 of 7 universities/systems as partners)
Alzheimer’s Initiative ($638M)
State
UT Brain Program
Chancellors Quantum Leap - Brain Health
UTS Neuroscience and Neurotechnology Research Institute formed
Neuroscience Council (2013)

10. Neurodysfunction Tactics Resource Requirements
Objective / Tactic / Sub-Tactic
Capital FY17
Capital FY18
One Time FY17
One Time FY18
Ongoing FY17
Ongoing FY18
New Faculty
New Staff
Expand interdisciplinary research activity in Neurodysfuntion by 4FQ17
Recruit PI/Co PI Expert(s) (One Time Expense identified for FY17 is already included in negotiated Start-up commitments) $
$ 5,000 $
Develop economically feasible models to engage physicians $ $
Focus on neurologic dysfunction samples
$ 1,500 $
Create specific seed grant program
Purchase Neuroimaging equipment (fMRI)
$ 2,500
2.00
Create "Research Marketing" catalog of fundable research strengths $
Grand Total
$ 4,200
$ 2,700
$ 5,000 $
$ 1,800
$ 2,350 -

11. Where do we go from here?
Executive Leadership Group (Institutional Planning)
Overview of the plan, priorities and recommendations
Seek partial funding for FY17 and build priorities into FY18 Capital and Operating budgets
Productivity Enhancement (80% of costs are in people)
Complete Centers and Institutes evaluation with recommendations for consolidation and redeployment of resources
Focused philanthropy
Evaluation of faculty research funding coverage expectations
Documentation and establishment of an acceptable threshold for unfunded research (12% – 35% nationally)